ES469749A1 - Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol. - Google Patents

Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.

Info

Publication number
ES469749A1
ES469749A1 ES469749A ES469749A ES469749A1 ES 469749 A1 ES469749 A1 ES 469749A1 ES 469749 A ES469749 A ES 469749A ES 469749 A ES469749 A ES 469749A ES 469749 A1 ES469749 A1 ES 469749A1
Authority
ES
Spain
Prior art keywords
nitroimidazole
composition
mono
nitroimidazole drug
lyophilize
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469749A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of ES469749A1 publication Critical patent/ES469749A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ES469749A 1977-05-14 1978-05-11 Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol. Expired ES469749A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2037977 1977-05-14

Publications (1)

Publication Number Publication Date
ES469749A1 true ES469749A1 (es) 1978-12-16

Family

ID=10144988

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469749A Expired ES469749A1 (es) 1977-05-14 1978-05-11 Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.

Country Status (16)

Country Link
JP (1) JPS542315A (pt)
AU (1) AU504551B1 (pt)
BE (1) BE867040A (pt)
DE (1) DE2820992A1 (pt)
DK (1) DK212678A (pt)
ES (1) ES469749A1 (pt)
FI (1) FI781507A (pt)
FR (1) FR2390162A1 (pt)
IL (1) IL54687A0 (pt)
IT (1) IT1115599B (pt)
LU (1) LU79655A1 (pt)
NL (1) NL7805158A (pt)
NO (1) NO781688L (pt)
PT (1) PT68034B (pt)
SE (1) SE7805471L (pt)
ZA (1) ZA782736B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070778D1 (en) * 1979-08-11 1985-07-25 Bayer Ag Antimycotic agents with enhanced release of the active ingredients
FR2624736B1 (fr) * 1987-12-16 1991-03-22 Dietlin Francois Nouvelles compositions pharmaceutiques dispersibles dans l'eau a base d'ornidazole
CN104127379A (zh) * 2014-08-14 2014-11-05 珠海亿邦制药股份有限公司 一种奥硝唑注射液及其制备方法
CN110538144A (zh) * 2019-06-13 2019-12-06 南京瓦尔生物医药有限公司 一种奥硝唑注射液和s-奥硝唑注射液

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032645A (en) * 1975-06-19 1977-06-28 G. D. Searle & Co. Injectable metronidazole composition

Also Published As

Publication number Publication date
BE867040A (fr) 1978-11-13
AU504551B1 (en) 1979-10-18
FR2390162A1 (fr) 1978-12-08
DK212678A (da) 1978-11-15
ZA782736B (en) 1979-05-30
DE2820992A1 (de) 1978-12-07
IL54687A0 (en) 1978-07-31
FI781507A (fi) 1978-11-15
NO781688L (no) 1978-11-15
JPS542315A (en) 1979-01-09
IT1115599B (it) 1986-02-03
IT7823351A0 (it) 1978-05-12
PT68034B (en) 1979-10-24
SE7805471L (sv) 1978-11-15
NL7805158A (nl) 1978-11-16
PT68034A (en) 1978-06-01
LU79655A1 (fr) 1979-12-06

Similar Documents

Publication Publication Date Title
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
SE8402549L (sv) Substituerade moranolinderivat
ES485062A1 (es) Un procedimiento para preparar derivados de acido acetico
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
IT7922743A0 (it) Componente di dosaggio farmaceutico a emissione controllata.
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
ES410825A1 (es) Procedimiento para la preparacion de derivados de quino- leina.
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
GB2000025A (en) Nitroimidazole formulations
HU172372B (hu) Insekticidnye kompozicii soderzhahhie zamehhennye proizvodnye oksi-piridina - zamehhennye slozhnom efirom n,n-dialkilaminokarbamidnojj kisloty i sposob poluchenija aktivnykh agentov
SE7902866L (sv) 3-0-(beta-d-glukuronopyranosyl)-sojasapogenol b
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
FR2392668A1 (fr) Medicament a base de coproporphyrine
ES466239A1 (es) Un procedimiento de preparacion de azacicloalcanos, azaci- cloalquenos y sus derivados
IT7823102A0 (it) Derivati di acidi azolil-alcan-carbossilici, procedimento per la loro preparazione e loro impiego come funghicidi.
IE35032B1 (en) Phenyl-azolyl-fatty acid derivatives,process for their production and their use as medicines
NL7509032A (nl) Werkwijze ter bereiding van gesubstitueerde 2h- -pyraan-2,6(3h)-dion derivaten, alsmede van far- maceutische preparaten die deze verbindingen als actieve component omvatten.
BE881317R (nl) Taurinederivaten met antilipemische en choleretische activiteit, werkwijze ter bereiding daarvan alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten
ES416766A1 (es) Un procedimiento para la preparacion de (3 - trifluormetil-fenoxi) - (4 - clorofenil) acetato de 2 - acetamidoetilo.
AU7971182A (en) Anthranilic acid derivatives
ES440208A1 (es) Procedimiento para la fabricacion de derivados de piperazi- na.
NL174522C (nl) Werkwijze ter bereiding van herbicide preparaten, alsmede ter bereiding van daarin als actieve bestanddelen aanwezige thiopropionzuurderivaten.
IT8112688A0 (it) Composto farmaceutico contenente 1.2.3.carbossipropionil ossietile 2 metile 5 nitroimidazolo quale agente terapeutico attivo contro le malattie causate da germi anaerobi
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
NL7805966A (nl) Nieuwe farmacologisch actieve gesubstitueerde azijn- zuuresters, werkwijzen ter bereiding daarvan en farmaceutische preparaten, die deze verbindingen bevat- ten.